Janus Kinase 2 (V617F) Mutation Status, Signal Transducer and Activator of Transcription-3 Phosphorylation and Impaired Neutrophil Apoptosis in Myelofibrosis With Myeloid Metaplasia

Leukemia - United Kingdom
doi 10.1038/sj.leu.2404338
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Janus Kinase V617F Mutation Detection in Patients With Myelofibrosis

Balkan Journal of Medical Genetics
Genetics
2019English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2014English

Epigenetic Regulation of Signal Transducer and Activator of Transcription 3 in Acute Myeloid Leukemia

Leukemia Research
Cancer ResearchOncologyHematology
2008English

Signal Transducer and Activator of Transcription 3 (STAT3)

Science-Business eXchange
2013English

STAT3 (Signal Transducer and Activator of Transcription 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Vitamin D Deficiency and Janus Kinase 2 V617F Mutation Status in Essential Thrombocythemia and Polycythemia Vera

Malaysian Journal of Medical Sciences
Medicine
2020English

The Janus Kinase Inhibitor JTE-052 Improves Skin Barrier Function Through Suppressing Signal Transducer and Activator of Transcription 3 Signaling

Journal of Allergy and Clinical Immunology
AllergyImmunology
2015English

Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer

Annals of the New York Academy of Sciences
GeneticsMolecular BiologyBiochemistryNeuroscienceHistoryPhilosophy of Science
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy